| abstract |
The present invention provides a method for treating heart failure and renal dysfunction in patients with stage B, stage C, or stage D heart failure and preventing mortality associated therewith and administering a therapeutically effective amount of CGRP Provide a method for improving the quality of life by providing a method. One method provides symptomatic relief in this patient, prevents exacerbation of symptoms, and / or during this number of days it is necessary to prevent and / or delay the progression of a heart failure condition. Administering between about 50 ng / min and about 500 ng / min of CGRP at a time between 30 minutes and 8 hours per day. This treatment can be administered on an outpatient or inpatient basis. |